Artificial urinary sphincters
€23M Series B extension from
← All transactions
UroMems: €12.5M Series B from btov, Financière Arbevel, Bpifrance, HIL-INVENT, Wellington Partners, Supernova Invest
Exclusive advisor to the company
- Date
- May 2020
- Sector
- Healthcare
- Business
- Artificial urinary sphincters
- Transaction
- €12.5M Series B from btov, Financière Arbevel, Bpifrance, HIL-INVENT, Wellington Partners, Supernova Invest
- Apparius’s role
- Exclusive advisor to the company
- Area of focus
- Medical devices
The Grenoble medtech raised €12.5 million from Austrian family office Hil-Invent, Financière Arbevel and its existing shareholders to complete pre-clinical trials and prepare the first clinical trials of its implantable urinary sphincter.
Other transactions with UroMems
Urology
€12M Series B from
